Clore Laboratory: News
Diabetes, Obesity and Metabolic Research

Home >> Clore Laboratory >> News >> News archive 2007

27 November 2007
Mike Cawthorne and Jon Arch key speakers at Terrapinn Obesity Drug Development conference

9 November 2007
Research on leptin and early life programming of skeletal muscle presented at DOHaD congress

24 September 2007
Mike Cawthorne to speak at SMi ‘Targeting Obesity’ conference

20 September 2007
Kenny Langlands joins editorial board of the Open Dermatology Journal

24 July 2007
Claire Stocker gives invited overview of fetal origins of obesity at ICT XI

30 June 2007
Poster presentation on THCV at ICRS 17th Annual Symposium on the Cannabinoids

30 May 2007
New glucokinase activator described in Diabetologia publication

14 March 2007
Clore Laboratory collaboration with Deakin University on gene studies

8 March 2007
Mike Cawthorne reviews obesity drug research for Foresight programme

21 February 2007
Peptide betagranin shows inhibitory effect on insulin secretion

15 February 2007
Jon Arch comment on leptin paper is published in Diabetologia

12 February 2007
Jon Arch keynote speaker at meeting on drug development for obesity

19 January 2007
Diet dependent improved glucose tolerance in DGAT1 null mice

18 January 2007
Programming effects of leptin published in American Journal of Physiology

6 January 2007
Studies contribute to successful outlicensing of glucose activator programme